NCT03819153), secondary analyses of GLP-1RA CVOTs indicate that liraglutide [17], semaglutide [18], dulaglutide [25] and efpeglenatide [20] may reduce the relative risk of a composite kidney outcome, comprising new-onset macroalbuminuria, worsening kidney function, end-stage renal disease and renal death, by 1536%
Your direct link to your brand profile: create free account to view reviews
A 2025 study demonstrated that the in vitro bias metric integrating cAMP signaling and -arrestin recruitment correlates more strongly with in vivo weight loss in diet-induced obese mice than cAMP potency alone (Douros et al., 2025)
Yes, a smaller one than if they charged each person the full sticker price (and each person was able to pay that price)
Clinical trials and post-marketing surveillance have not identified hypokalaemia as a significant safety signal with Mounjaro therapy
The researchers used cultured human fibroblasts obtained from cervical skin that was either intact or exposed to radioactive treatment (5000 rad)